Search hospitals > Alabama > Mobile
Mobile Infirmary Medical Center
Claim this profileMobile, Alabama 36607
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Head and Neck Cancers
Conducts research for Esophageal Cancer
Conducts research for Lung Cancer
89 reported clinical trials
8 medical researchers
Summary
Mobile Infirmary Medical Center is a medical facility located in Mobile, Alabama. This center is recognized for care of Breast Cancer, Cancer, Head and Neck Cancers, Esophageal Cancer, Lung Cancer and other specialties. Mobile Infirmary Medical Center is involved with conducting 89 clinical trials across 145 conditions. There are 8 research doctors associated with this hospital, such as Kannan Thanikachalam, Furhan Yunus, John R. Russell, and Jan O. Kemnade.Area of expertise
1Breast Cancer
Global LeaderHER2 positive
ER positive
ER negative
2Cancer
Global Leaderp16 positive
HER2 positive
p16 negative
Top PIs
Kannan ThanikachalamThomas Hospital3 years of reported clinical research
Studies Pancreatic Cancer
Studies Adenocarcinoma
5 reported clinical trials
16 drugs studied
Furhan YunusMobile Infirmary Medical Center2 years of reported clinical research
Studies Cancer
Studies Head and Neck Cancers
4 reported clinical trials
25 drugs studied
John R. RussellMobile Infirmary Medical Center7 years of reported clinical research
Studies Adenocarcinoma
Studies Prostate Cancer
4 reported clinical trials
13 drugs studied
Jan O. KemnadeMichael E DeBakey VA Medical Center2 years of reported clinical research
Studies Cancer
Studies COVID-19
3 reported clinical trials
6 drugs studied
Clinical Trials running at Mobile Infirmary Medical Center
Breast Cancer
Melanoma
Pancreatic Cancer
Oropharyngeal Carcinoma
Oropharyngeal Cancer
Cancer
Squamous Cell Carcinoma
Cutaneous Melanoma
Stroke
Skin Cancer
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This study is evaluating whether a combination of two drugs may help prevent breast cancer from coming back.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mobile Infirmary Medical Center?
Mobile Infirmary Medical Center is a medical facility located in Mobile, Alabama. This center is recognized for care of Breast Cancer, Cancer, Head and Neck Cancers, Esophageal Cancer, Lung Cancer and other specialties. Mobile Infirmary Medical Center is involved with conducting 89 clinical trials across 145 conditions. There are 8 research doctors associated with this hospital, such as Kannan Thanikachalam, Furhan Yunus, John R. Russell, and Jan O. Kemnade.